Myasthenia Gravis - Drug Pipeline Landscape, 2022

Myasthenia gravis is a chronic autoimmune neuromuscular condition that causes muscle weakness and severe fatigue. It causes weakness in the skeletal muscles, which are the muscles your body uses for movement. Myasthenia gravis is caused by a breakdown in the normal communication between nerves and muscles.

Healthcare professional checks neurological health by testing reflexes, muscle strength, muscle tone etc. Ice pack test, antibody tests, imaging scans and electromyogram can also be used for diagnosis. Myasthenia gravis treatments include medications, monoclonal antibodies, iv immunoglobulin (ivig), plasma exchange (plasmapheresis) and surgery. The companies active in development of Myasthenia Gravis Drugs are Ahead Therapeutics, Alexion Pharmaceuticals, AnTolRx, Argenx, Cabaletta Bio etc.

Read more about Myasthenia Gravis - Drug Pipeline Landscape here: https://www.globalinsightservices.com/reports/myasthenia-gravis-drug-pipeline-landscape-2022/

Report Highlights
Global Insight Service's, Myasthenia Gravis - Drug Pipeline Landscape, 2022 report provides an overview of the Myasthenia gravis pipeline drugs. This report covers detailed insights on Myasthenia Gravis drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Myasthenia Gravis pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

To remain 'ahead' of your competitors, request for a sample: https://www.globalinsightservices.com/request-sample/GIS31033/

Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.

Key Players:

- Ahead Therapeutics
- Alexion Pharmaceuticals
- AnTolRx
- Argenx
- Cabaletta Bio
- Cartesian Therapeutics
- Catalyst Pharmaceuticals, Inc.
- CSL Behring

Get a Customized Scope to Match Your Need Ask an Expert: https://www.globalinsightservices.com/request-customization/GIS31033/

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.